Why Monitor AUC?
A measured drug concentration is a snapshot: its value depends on when the sample was taken and on the concentration-time profile around that time. AUC, or area under the concentration-time curve, summarizes exposure across a specified time interval. It can therefore be a more informative monitoring target when the clinical effect is related to overall exposure rather than to one particular point in the dosing cycle.
This does not make AUC universally superior. A peak or trough can be the more relevant target when efficacy or toxicity is tied to that part of the profile. The choice depends on the drug-specific exposure–response evidence and the clinical question. AUC is especially useful for comparing total exposure across regimens or patients when a single concentration could be misleading because profiles differ in shape.
An AUC target is not a target concentration at a particular sampling time. It describes the accumulated concentration-time exposure over a defined interval. The interval and dosing conditions must be clear when interpreting the target: an AUC over 24 hours, for example, is not interchangeable with an AUC over 12 hours.
Relating Interval AUC to Dose and Clearance
Under linear pharmacokinetics, clearance relates the rate of drug elimination to concentration. If clearance \(CL\) is constant over the interval, the amount eliminated is \(CL\) multiplied by the concentration integrated over time. At steady state, the amount of drug in the body at the beginning and end of a dosing interval is the same. Consequently, the amount entering the systemic circulation during the interval must equal the amount eliminated during that interval.
The derivation follows directly from the steady-state amount balance. With linear clearance, the elimination rate at time \(t\) is \(CL \cdot C(t)\); integrating this rate over an interval gives the eliminated amount. At steady state, that amount equals the systemic input. Thus:
Solving for the integral gives the interval-AUC relationship above. This result assumes that clearance is constant and linear across the concentrations encountered, the dose and bioavailability are stable, and the interval represents steady-state dosing. It is a relationship for exposure over a complete dosing interval; it does not tell us the concentration at any particular time within that interval.
Worked Example: Calculating AUC After an Intravenous Dose
Suppose a hypothetical patient receives 600 mg intravenously every 24 hours. Assume the patient is at steady state and has constant clearance of 4.0 L/h. Calculate the AUC over one dosing interval and the average concentration over that interval.
For intravenous dosing, \(F=1\). The interval AUC is:
The average concentration is the interval AUC divided by the interval length:
Under the stated assumptions, the hypothetical patient’s average concentration over the 24-hour interval is 6.25 mg/L. This does not mean the concentration remains at 6.25 mg/L: the peak and trough may be higher and lower, respectively.
For a fixed dose per interval, the steady-state interval AUC is determined by systemic dose and clearance, not by the interval length on its own. Changing the interval can change the concentration-time profile, including its peaks and troughs, even when the total AUC per interval is unchanged. When comparing average exposure over time, the interval length matters: average concentration is interval AUC divided by \(\tau\).
When AUC Adds Information Beyond One Concentration
A single concentration can be informative when it is collected at the relevant time and the target is tied to that point in the profile. But the same measured value can occur in profiles with different overall exposure. One profile might have a brief high concentration followed by a rapid decline; another might rise or decline more gradually. A sample at a particular time does not, by itself, reveal the area under either profile.
The following example uses stylized concentration curves to isolate this distinction. The curves are illustrative, not mechanistic pharmacokinetic models.
Worked Example: The Same Sampled Concentration, Different AUC
Consider two hypothetical concentration profiles over a 24-hour interval, with concentration measured in mg/L and time in hours. Let the profiles be \(C_A(t)=4+2\cos(2\pi t/24)\) and \(C_B(t)=3+\cos(2\pi t/24)\). A sample is taken at \(t=12\) hours. Compare the sampled concentrations and the interval AUCs.
At 12 hours, \(\cos(2\pi \cdot 12/24)=\cos(\pi)=-1\). Therefore:
The sample concentrations are identical. To obtain the AUC for each specified curve, integrate over the full interval. The cosine term completes one full cycle over 24 hours, so its integral over that interval is zero:
The two profiles have the same concentration at the sample time but different interval AUCs. This demonstrates why one concentration cannot generally determine total exposure without additional information about the profile or a suitable model. In practice, the stylized curves are not a method for estimating AUC; they illustrate the distinction between a snapshot and an interval summary.
AUC can be particularly useful when the clinical target concerns cumulative exposure, or when different dosing regimens produce different peak-to-trough patterns but total exposure is the primary quantity of interest. A single peak or trough remains preferable when the relevant decision is specifically about peak-related toxicity, a minimum concentration needed through the interval, or another time-local effect.
Worked Example: Adjusting an Oral Dose for an AUC Target
Suppose a hypothetical oral drug has a target steady-state AUC over 24 hours of 80 mg·h/L. A patient’s clearance is estimated to be 5.0 L/h, and the fraction of the oral dose reaching systemic circulation is assumed to be \(F=0.80\). Under the linear, steady-state assumptions, what oral dose per 24-hour interval corresponds to this target?
Rearrange the relationship \(\mathrm{AUC}_{24,\mathrm{ss}}=F\cdot\mathrm{Dose}/CL\) to solve for dose:
Substitute the target and patient-specific values:
The calculated dose is 500 mg orally per 24-hour interval. The units reduce to mg because \((\mathrm{mg\cdot h/L})(\mathrm{L/h})=\mathrm{mg}\). This is a model-based calculation, not a dosing recommendation: it depends on the accuracy of the target, clearance, and bioavailability assumptions, as well as the drug’s linearity over the relevant dose range.
Assumptions, Diagnostics, and Limitations
The dose-to-AUC relationship is useful because it provides a direct link between systemic dose, clearance, and total exposure. Its reliability depends on the conditions under which it was derived. Before interpreting an AUC target through this relationship, check that the dose and interval are known, the interval is complete, the patient’s dosing is sufficiently consistent for the intended steady-state interpretation, and clearance and bioavailability are reasonably stable.
The relationship can fail or become misleading when clearance changes over time, elimination is nonlinear over the concentration range, bioavailability varies, or doses are missed. In such settings, multiplying concentration by a single constant clearance may not represent the amount eliminated over the whole interval. AUC may still be a useful exposure summary, but the simple dose-to-AUC equation cannot be used without qualification.
AUC also has an interpretive limitation: it compresses a concentration-time profile into one number. Two profiles can have the same AUC but substantially different peaks, troughs, or time spent above a clinically relevant concentration. AUC alone cannot establish that these features are acceptable. It should be selected because it matches the clinical exposure question, not merely because it is a convenient summary.
| Monitoring target | What it summarizes | When it can be most informative | Important limitation |
|---|---|---|---|
| AUC over an interval | Total concentration-time exposure over the specified interval | When the target concerns overall exposure or regimen comparisons | Does not describe the exact peak, trough, or profile shape |
| Peak concentration | Concentration near the maximum of the profile | When peak-related efficacy or toxicity is the clinical concern | Does not by itself summarize exposure through the interval |
| Trough concentration | Concentration near the end of the dosing interval | When maintaining a minimum concentration is important | Does not by itself establish the interval AUC |
A common mistake is to reason that a concentration inside its target range proves the AUC is also in range. That conclusion does not follow: one value does not determine the area under an otherwise unspecified curve. The correction is to interpret the measurement against the target it was designed to assess. If the target is AUC, the monitoring approach must provide a defensible estimate of AUC; a single concentration is not automatically a substitute.
A second mistake is to treat \(F\cdot\mathrm{Dose}/CL\) as a universal prediction for every interval and patient. The equation applies under its stated assumptions, including linear, stable clearance and steady-state interval dosing. If those assumptions are not reasonable, the calculation should not be presented as though it were exact.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions.
- An intravenous dose of 450 mg is given every 12 hours to a hypothetical patient with constant clearance of 3.0 L/h at steady state. What is the interval AUC?
- An oral drug has \(F=0.75\), clearance of 6.0 L/h, and a dose of 600 mg per interval. Under the stated assumptions, calculate the interval AUC.
- Why can two patients have the same concentration at a sampling time but different AUCs?
- State two assumptions required to use \(\mathrm{AUC}_{\tau,\mathrm{ss}}=F\cdot\mathrm{Dose}/CL\).
- When might a peak or trough be more informative than AUC?
Solutions. (1) For IV dosing, \(F=1\), so \(\mathrm{AUC}_{12,\mathrm{ss}}=450\ \mathrm{mg}/(3.0\ \mathrm{L/h})=150\ \mathrm{mg\cdot h/L}\). (2) \(\mathrm{AUC}_{\tau,\mathrm{ss}}=(0.75)(600\ \mathrm{mg})/(6.0\ \mathrm{L/h})=75\ \mathrm{mg\cdot h/L}\). (3) The sampled value describes concentration at one time, while AUC depends on the concentration profile across the whole interval; profiles can cross at the sample time and still enclose different areas. (4) Any two of: linear and time-invariant clearance, steady-state dosing over a complete interval, stable dose, or stable bioavailability. (5) A peak is more informative when peak-related effects are the concern; a trough is more informative when maintaining a minimum concentration is the concern.